PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 135 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $89,838 | -27.3% | 5,386 | +20.3% | 0.00% | -20.0% |
Q2 2023 | $123,655 | +53.6% | 4,477 | +27.9% | 0.01% | +66.7% |
Q1 2023 | $80,523 | +100.5% | 3,501 | 0.0% | 0.00% | +50.0% |
Q4 2022 | $40,156 | +38.5% | 3,501 | 0.0% | 0.00% | +100.0% |
Q3 2022 | $29,000 | +7.4% | 3,501 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $27,000 | -67.5% | 3,501 | 0.0% | 0.00% | -66.7% |
Q1 2022 | $83,000 | -30.8% | 3,501 | 0.0% | 0.00% | -25.0% |
Q4 2021 | $120,000 | +110.5% | 3,501 | +8.0% | 0.00% | +100.0% |
Q3 2021 | $57,000 | -60.7% | 3,241 | 0.0% | 0.00% | -60.0% |
Q2 2021 | $145,000 | +93.3% | 3,241 | +11.7% | 0.01% | +66.7% |
Q1 2021 | $75,000 | +44.2% | 2,901 | +12.4% | 0.00% | +50.0% |
Q4 2020 | $52,000 | +4.0% | 2,581 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $50,000 | +42.9% | 2,581 | +29.4% | 0.00% | 0.0% |
Q2 2020 | $35,000 | +288.9% | 1,995 | +49.2% | 0.00% | +100.0% |
Q1 2020 | $9,000 | 0.0% | 1,337 | 0.0% | 0.00% | – |
Q4 2019 | $9,000 | -43.8% | 1,337 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $16,000 | 0.0% | 1,337 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $16,000 | +100.0% | 1,337 | +37.8% | 0.00% | – |
Q1 2018 | $8,000 | -27.3% | 970 | +88.7% | 0.00% | -100.0% |
Q4 2017 | $11,000 | +37.5% | 514 | 0.0% | 0.00% | – |
Q3 2017 | $8,000 | +33.3% | 514 | 0.0% | 0.00% | – |
Q2 2017 | $6,000 | -14.3% | 514 | 0.0% | 0.00% | – |
Q1 2017 | $7,000 | – | 514 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $67,646,434 | 21.00% |
COWEN AND COMPANY, LLC | 1,657,551 | $45,781,558 | 3.80% |
Kynam Capital Management, LP | 975,298 | $26,937,731 | 3.70% |
BVF INC/IL | 3,775,900 | $104,290,358 | 2.91% |
RTW INVESTMENTS, LP | 5,415,514 | $149,576,497 | 2.85% |
Cormorant Asset Management, LP | 1,500,000 | $41,430,000 | 2.32% |
Ghost Tree Capital, LLC | 225,000 | $6,214,500 | 2.05% |
683 Capital Management, LLC | 814,000 | $22,482,680 | 1.62% |
Perceptive Advisors | 1,469,761 | $40,594,799 | 1.18% |
Artia Global Partners LP | 112,340 | $3,102,831 | 1.07% |